We’ve developed a vast number of reference materials—everything from comprehensive reporting and drug monitoring testing guides, to Health Trends® reports that provide insights into the drug misuse epidemic in the US—that can help empower better patient care and help you make more informed decisions in the fight against drug misuse.
Download these helpful resources to navigate our broad menu of tests, including prescription drug medications, other controlled medications, and illicit drugs.
A complete reference guide by drug class, including our full test menu
Our full test menu, including test codes and panels available
Novel Psychoactive Substances (NPS) are a growing, persistent challenge in an ever-changing drug epidemic. The resource below provides an overview of NPS and illustrates the importance of definitive testing for NPS to help identify misuse.
The following resources are provided to help physicians understand oral fluid sample collection and to assist patients in completing self-collection of lab samples for physician-ordered drug monitoring tests.
After more than 20 years, the drug epidemic continues to be an evolving and widespread public health issue. Novel Psychoactive Substances (NPS) are at the epicenter of the epidemic and are fast seeping into the nation’s drug supply. In our latest Quest Diagnostics Health Trends® report, we found that approximately 13.1% of remnant specimens tested were positive for at least 1 NPS and 42% of all positive samples had more than 1 NPS present—highlighting the importance of definitive testing to help identify noncompliance and potential misuse.
Ten years ago, drug overdoses claimed nearly 42,000 lives annually in the United States. By the end of 2021, that number rose to nearly 108,000. Fueled by increased access to illicit drugs as well as barriers to healthcare access exacerbated by the COVID-19 pandemic, it’s clear the drug crisis shows no signs of abating. That’s just 1 of the startling findings presented in Drug Misuse in America 2022: A Decade Lost to the Drug Crisis, a Quest Diagnostics Health Trends annual report that examines more than 20 million deidentified clinical drug tests over 10 years.
Drug Misuse in America 2021: Physician Perspectives and Diagnostic Insights on the Drug Crisis and COVID-19, a Quest Diagnostics Health Trends report, explores the impact of the pandemic on drug misuse using nearly 5 million deidentified laboratory tests performed by Quest Diagnostics from 2011 through 2020 for patients in all 50 states and the District of Columbia.
The report is believed to be the first of its kind that juxtaposes laboratory test results with findings from an online survey of 505 US primary care physicians about the use of controlled prescription medications and illicit drugs in the United States during the COVID-19 pandemic.
As an industry leader in drug testing, Quest Diagnostics provides a wealth of information and resources to help you make more informed decisions for your patients.
Video – Why Every Clinician Needs to Integrate Drug Monitoring into their Practice with Jeff Gudin, MD
Video - How to Set the Stage for a Drug Monitoring Program with your Patient with Jeff Gudin, MD
Video - How to Share Drug Monitoring Results with Your Patient with Jeff Gudin, MD
1.877.40.RXTOX (1.877.407.9869)
1.866.MY.QUEST (1.866.697.8378)
Your Privacy Choices
Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services. Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services.
Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.
